Abbott, Biotest to collaborate over mid-stage drug - BusinessWeek

Abbott, Biotest to collaborate over mid-stage drug BusinessWeek Abbott Laboratories aforementioned Tuesday that it faculty pay German company Biotest AG $85 million upfront and royalty and marker payments that could full $395 million as component part of a collaboration concluded a potential rheumatoid arthritis and psoriasis treatment. ... Abbott, Biotest To unit Up On Treatment For Arthritis, Psoriasis Wall Street Journal Abbott, Biotest signed RA, psoriasis drug development pact Pharmaceutical Business revaluation Abbott, Biotest seal deal over arthritis drug Reuters Proactive Investors USA & Canada  - FierceBiotech  - Zenopa all 49 tidings articles » Link To Article